Based on these observations, we proposed that IRF7 can up-regulate the expression of ACE2, either directly (binding to the promoter) or indirectly (through IFN-α) in AD, which may help the brain’s entry of SARS-CoV-2. Here, IFNA2 is linked to Alzheimer disease.